BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 6985528)

  • 1. [Malignant and benign lymphomas: histologic classification and immunomorphologic studies. Results of 838 cases].
    Radaszkiewicz T
    Wien Klin Wochenschr; 1980 Dec; 92(23):819-33. PubMed ID: 6985528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-Hodgkin's lymphomas: an immunohistochemical and histological study.
    Curran RC; Jones EL
    J Pathol; 1979 Dec; 129(4):179-90. PubMed ID: 317105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dendritic reticulum cell immunoreactivity for low-affinity nerve growth factor receptor in malignant lymphomas.
    Dorfman DM; Shahsafaei A
    Mod Pathol; 1996 Oct; 9(10):959-65. PubMed ID: 8902831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Nucleolar organizer as a marker of malignancy grade and prognosis of non-Hodgkin's malignant lymphoma].
    Raĭkhlin NT; Bukaeva IA; Probatova NA; Smirnova EA; Tupitsyn NN; Sholokhova EN
    Arkh Patol; 1996; 58(4):22-8. PubMed ID: 8967858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Retrospective analysis of the clinical relevance of the Kiel classification of malignant non-Hodgkin's lymphomas (author's transl)].
    Brittinger G; Bartels H; Bremer K; Burger A; Dühmke E; Gunzer U; König E; Stacher A; Stein H; Theml H; Waldner R
    Strahlentherapie; 1977 Apr; 153(4):222-8. PubMed ID: 324031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [R.E.A.L. classification of non-Hodgkin lymphoma from the clinico-oncologic viewpoint].
    Meusers P; Brittinger G
    Praxis (Bern 1994); 1998 Jun; 87(23):793-800. PubMed ID: 9654985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Non-Hodgkin's lymphomas: principles and application of the Kiel classification].
    Lennert K
    Verh Dtsch Ges Pathol; 1992; 76():1-13. PubMed ID: 1283238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Histopathology of malignant lymphomas].
    Yamabe H
    Rinsho Byori; 1990 Apr; 38(4):386-9. PubMed ID: 2195192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MIB1 (Ki-67) expression in non-Hodgkin's lymphomas.
    Kalogeraki A; Tzardi M; Panagiotides I; Koutsoubi K; Bolioti S; Rontogianni D; Stefanaki K; Zois E; Karidi E; Darivianaki K; Delides G; Kanavaros P
    Anticancer Res; 1997; 17(1A):487-91. PubMed ID: 9066700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The results of histological and immunohistological studies of primary biopsies in 400 patients with non-Hodgkin's lymphoma in the North-West region of Russia (according to WHO classification)].
    Krivolapov IuA
    Ter Arkh; 2004; 76(7):64-70. PubMed ID: 15379131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytotoxic protein expression in non-Hodgkin's lymphomas and Hodgkin's disease.
    Kanavaros P; Vlychou M; Stefanaki K; Rontogianni D; Gaulard P; Pantelidaki E; Zois M; Darivianaki K; Georgoulias V; Boulland ML; Gorgoulis V; Kittas C
    Anticancer Res; 1999; 19(2A):1209-16. PubMed ID: 10368677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Demonstration of immunoglobulin production by tumor cells in non-Hodgkin's and Hodgkin's malignant lymphomas and its significance for their classification.
    Stein H; Papadimitriou CS; Bouman H; Lennert K; Fuchs J
    Recent Results Cancer Res; 1978; 64():158-75. PubMed ID: 366694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunophenotyping of non-Hodgkin's lymphomas using a panel of antibodies on paraffin-embedded tissues.
    Davey FR; Gatter KC; Ralfkiaer E; Pulford KA; Krissansen GW; Mason DY
    Am J Pathol; 1987 Oct; 129(1):54-63. PubMed ID: 3310651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serous effusions in malignant lymphomas: a review.
    Das DK
    Diagn Cytopathol; 2006 May; 34(5):335-47. PubMed ID: 16604559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hodgkin's and non-Hodgkin's lymphoma of the head and neck.
    Urquhart A; Berg R
    Laryngoscope; 2001 Sep; 111(9):1565-9. PubMed ID: 11568605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Transformation of malignant non-Hodgkin's lymphomas from low- to high-grade malignancy].
    Herait P; Audouin J; Rio B; Zylberait D; Marie JP; Diebold J; Zittoun R
    Ann Med Interne (Paris); 1986; 137(4):342-5. PubMed ID: 3777743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malignant lymphomas in Korea.
    Chi JG; Shin SS; Ahn GH; Lee SK
    Jpn J Clin Oncol; 1985 Dec; 15(4):653-9. PubMed ID: 4094098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical data and therapy of malignant non-Hodgkin's lymphoma of nasal cavity and paranasal sinuses (author's transl)].
    Löbe LP; Katenkamp D
    Laryngol Rhinol Otol (Stuttg); 1981 Jun; 60(6):334-7. PubMed ID: 6894956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A review of childhood cases of malignant lymphoma in Osaka, Japan].
    Ohsawa M; Matsumoto M; Aozasa K; Tamai M; Tsujimura S; Kohro T
    Gan No Rinsho; 1989 Apr; 35(5):609-13. PubMed ID: 2716191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Dipeptidyl aminopeptidase-IV as a histochemical marker of differential diagnosis of large cell anaplastic CD30+-lymphoma and Hodgkin's disease].
    Raĭkhlin NT; Bukaeva IA; Probatova NA; Smirnova EA; Pavlovskaia AI; Tupitsyn NN; Sholokhova EN
    Arkh Patol; 2000; 62(4):3-8. PubMed ID: 10971865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.